Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness

NCT02025439 is registered in ClinicalTrials.gov with Edward Hines Jr. VA Hospital as lead sponsor.

NCT NCT02025439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02025439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness
Lead sponsor
Edward Hines Jr. VA Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2014
Completion date
July 31, 2016
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury